Table: RaQualia Pharma -Q1 group results

RaQualia Pharma

15/05/2026 07:38

May 15 (Reuters)- 
             RaQualia Pharma Inc 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended       Year to  
                Mar 31, 2026        Mar 31, 2025      Dec 31, 2026 
                   LATEST             YEAR-AGO           LATEST    
                   RESULTS             RESULTS          FORECAST   
  Sales            801 mln             965 mln            3.98     
                 (-16.9 pct)         (+48.8 pct)                   
  Operating     loss 160 mln           93 mln           165 mln    
                                    (+109.2 pct)      (-65.9 pct)  
  Recurring     loss 158 mln           29 mln            86 mln    
                                                      (-80.4 pct)  
  Net           loss 225 mln         loss 5 mln       loss 63 mln  
  EPS           loss 8.84 yen       loss 0.24 yen    loss 2.58 yen 
  Ann Div                                NIL              NIL      
  -Q2 div                                NIL              NIL      
  -Q4 div                                NIL              NIL      
  
  NOTE - RaQualia Pharma Inc. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4579.T